Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Should remaining stockpiles of smallpox virus (variola) be destroyed?

Weinstein RS.

Emerg Infect Dis. 2011 Apr;17(4):681-3. doi: 10.3201/eid1704.101865. Review.

2.

Smallpox virus destruction and the implications of a new vaccine.

Henderson DA.

Biosecur Bioterror. 2011 Jun;9(2):163-8. doi: 10.1089/bsp.2011.0011. Epub 2011 Mar 16.

PMID:
21410355
3.

[Should the human smallpox virus (variola) be destroyed?].

Tryland M.

Tidsskr Nor Laegeforen. 2004 Oct 21;124(20):2642-3. Norwegian.

4.

Keeping the memory of smallpox virus.

Puissant B, Combadière B.

Cell Mol Life Sci. 2006 Oct;63(19-20):2249-59. Review.

PMID:
16964577
5.

Bioterrorism. Smallpox vaccinations: how much protection remains?

Cohen J.

Science. 2001 Nov 2;294(5544):985. No abstract available.

PMID:
11691969
6.

Why not destroy the remaining smallpox virus stocks?

Lane JM, Poland GA.

Vaccine. 2011 Apr 5;29(16):2823-4. doi: 10.1016/j.vaccine.2011.02.081. Epub 2011 Mar 2. No abstract available.

PMID:
21376120
7.

Smallpox vaccination: a conundrum of risks and outcomes.

Milgrom H, Palmer E, Leung D.

Curr Opin Allergy Clin Immunol. 2005 Jun;5(3):207-9. No abstract available.

PMID:
15864076
8.

The immunology of smallpox vaccines.

Kennedy RB, Ovsyannikova IG, Jacobson RM, Poland GA.

Curr Opin Immunol. 2009 Jun;21(3):314-20. doi: 10.1016/j.coi.2009.04.004. Epub 2009 Jun 11. Review.

9.

Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists.

Ein D, Gruchalla R, Baker JR, Bellanti JA, Engler RA, Jones JF, Martin BL, Routes JM; Task Force on Smallpox Vaccination for Allergists.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):4-7. Review. No abstract available.

PMID:
15702806
10.

Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.

Meseda CA, Weir JP.

Future Microbiol. 2010 Sep;5(9):1367-82. doi: 10.2217/fmb.10.98. Review.

PMID:
20860482
11.

Smallpox vaccines: targets of protective immunity.

Moss B.

Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x. Review.

12.

Smallpox eradication: destruction of variola virus stocks.

[No authors listed]

Wkly Epidemiol Rec. 2002 Feb 1;77(5):34-8. English, French. No abstract available.

PMID:
11840681
13.

Addressing challenges for allergists in vaccination to protect against smallpox.

Hackett CJ, Rotrosen D, Plaut M.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):1-3. No abstract available.

PMID:
15702805
14.
15.

Immunomodulator-based enhancement of anti smallpox immune responses.

Martínez O, Miranda E, Ramírez M, Santos S, Rivera C, Vázquez L, Sánchez T, Tremblay RL, Ríos-Olivares E, Otero M.

PLoS One. 2015 Apr 13;10(4):e0123113. doi: 10.1371/journal.pone.0123113. eCollection 2015.

16.

The remaining stocks of smallpox virus should be destroyed.

Mahy BW, Almond JW, Berns KI, Chanock RM, Lvov DK, Pettersson RF, Schatzmayr HG, Fenner F.

Science. 1993 Nov 19;262(5137):1223-4. No abstract available.

PMID:
8235651
17.

Design and development of oral drugs for the prophylaxis and treatment of smallpox infection.

Painter GR, Hostetler KY.

Trends Biotechnol. 2004 Aug;22(8):423-7.

PMID:
15283988
18.

Eradication. Pressure growing to set a date to destroy remaining smallpox stocks.

Kaiser J.

Science. 2011 Jan 28;331(6016):389. doi: 10.1126/science.331.6016.389. No abstract available.

PMID:
21273461
19.

Smallpox. WHO puts off destruction of U.S., Russian caches.

Stone R.

Science. 2002 Jan 25;295(5555):598-9. No abstract available.

PMID:
11809941
20.

Remaining questions about clinical variola major.

Lane JM.

Emerg Infect Dis. 2011 Apr;17(4):676-80. doi: 10.3201/eid1704.101960. Review.

Supplemental Content

Support Center